111 Investor Relations Material
Latest events
Status Update
111
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from 111 Inc
Access all reports
111, Inc. operates as a digital healthcare platform in China, focusing on connecting patients with pharmaceutical products and healthcare services through both online and offline channels. The company operates in two main segments: B2C (business-to-consumer) and B2B (business-to-business). The B2C segment includes online retail of prescription and over-the-counter drugs, nutritional supplements, medical supplies, and personal care products. The B2B segment involves an online wholesale pharmacy platform that serves other pharmacies and healthcare providers. Additionally, 111, Inc. offers online consultation, electronic prescription services, and patient management services through its internet hospital. Headquartered in Shanghai, 111, Inc.'s shares are listed on the NASDAQ.
Key slides for 111 Inc
Latest articles
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
Ticker symbol
YI
Country
🇺🇸 United States